Begrivac

New Zealand - English - Medsafe (Medicines Safety Authority)

Buy It Now

Active ingredient:
Influenza virus haemagglutinin type A/Moscow/10/99 H3N2 - like strain 15 µg; Influenza virus haemagglutinin type A/New Caledonia/20/99 H1N1-like strain 15 µg; Influenza virus haemagglutinin type B/Sichuan/379/99 - like strain 15 µg
Available from:
Novartis New Zealand Ltd
INN (International Name):
Influenza virus haemagglutinin type A/Moscow/10/99 H3N2 - like strain 15 µg
Dosage:
0.5 mL
Pharmaceutical form:
Suspension for injection
Composition:
Active: Influenza virus haemagglutinin type A/Moscow/10/99 H3N2 - like strain 15 µg Influenza virus haemagglutinin type A/New Caledonia/20/99 H1N1-like strain 15 µg Influenza virus haemagglutinin type B/Sichuan/379/99 - like strain 15 µg Excipient: Ether Formaldehyde Phosphate Buffered Saline Polymyxin B Polysorbate 80 Sucrose
Units in package:
Syringe, glass, Prefilled single 0.5ml dose, 1 dose unit
Class:
Prescription
Prescription type:
Prescription
Manufactured by:
GSK Vaccines GmbH
Product summary:
Package - Contents - Shelf Life: Syringe, glass, Prefilled single 0.5ml dose - 1 dose units - 12 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) - Syringe, glass, 0.5mL syringe, 10 pack - 10 dose units - 12 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze)
Authorization number:
TT50-6476
Authorization date:
1999-11-12

Similar products

Search alerts related to this product

Share this information